New PSMA scan aims to spot hidden prostate cancer spread

NCT ID NCT04745871

Terminated Diagnosis Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a special type of PET/CT scan, called PSMA PET/CT, can better detect if prostate cancer has spread to nearby lymph nodes before surgery. The scan uses a radioactive tracer that sticks to prostate cancer cells, making them visible. The goal was to help doctors plan more precise surgery for men with intermediate- or high-risk prostate cancer. However, the trial was stopped early, so we have less information than planned.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: PSMA PET/CT scan (a type of imaging test using a radioactive tracer)
What this could lead to: If successful, this imaging test could help doctors more accurately decide the extent of surgery needed for prostate cancer, potentially reducing unnecessary procedures.
What could go wrong: The trial was terminated early, so results are limited. PSMA PET/CT is still being studied and may not be widely available or better than current standard imaging for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

CHRU de Brest

Brest, 29609, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.